NCT01898624已完成不适用
Specified Drug Use-results Survey of Betanis Tablets in OAB Patients With Coexisting Glaucoma
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 300
- 主要终点
- The occurrence of ocular adverse events such as increased intraocular pressure and worsening of glaucoma
研究概览
简要总结
To investigate the effects of mirabegron on the symptoms of glaucoma in overactive bladder (OAB) patients with coexisting glaucoma.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •diagnosed as OAB and treated with mirabegron
- •diagnosed as glaucoma (including normal tension glaucoma)
- •having intraocular pressure measurement conducted more than twice within six months before the start of the mirabegron treatment
排除标准
- 未提供
研究组 & 干预措施
Betanis group
mirabegron treated group
干预措施: mirabegron (Drug)
结局指标
主要结局
The occurrence of ocular adverse events such as increased intraocular pressure and worsening of glaucoma
时间窗: 12 weeks
次要结局
- Changes in OABSS (Over Active Bladder Symptoms Score)(Baseline and 12 weeks of treatment)
研究者
相似试验
已完成
3 期
Mirabegron Treatment on Patients With Overactive Bladder Syndrome in TaiwanUrinary IncontinenceOveractive Bladder SyndromeNCT03059134Buddhist Tzu Chi General Hospital168
已完成
4 期
Efficacy and Safety of the Mirabegron Compared With Solifenacin in Treatment of Overactive BladderOveractive BladderNCT03558919Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh81
Unknown
4 期
Mirabegron for Treatment of Overactive Bladder Symptoms in Patients With Parkinson's DiseaseOveractive BladderParkinson DiseaseNCT03412513Seoul National University Hospital144
已完成
不适用
The effect of mirabegron on female sexual functioISRCTN17199301Elpis Hospital70
已完成
4 期
Mirabegron in Parkinson Disease and Impaired CognitionImpaired CognitionOveractive BladderParkinson DiseaseNCT02536976HealthPartners Institute7